TGFB1 and ovarian carcinoma: Blocking TGF-β/Smad signaling in CAFs using TGF-β receptor inhibitors (ALK inhibitors) or Smad inhibitor SIS3 significantly inhibited the aggressive phenotypes of ovarian cancer cells in a co-culture model [73], suggesting that activation of Smad signaling in CAFs promotes tumor progression.